TY - JOUR
T1 - Distinctive features of single nucleotide alterations in induced pluripotent stem cells with different types of DNA repair deficiency disorders
AU - Okamura, Kohji
AU - Sakaguchi, Hironari
AU - Sakamoto-Abutani, Rie
AU - Nakanishi, Mahito
AU - Nishimura, Ken
AU - Yamazaki-Inoue, Mayu
AU - Ohtaka, Manami
AU - Periasamy, Vaiyapuri Subbarayan
AU - Alshatwi, Ali Abdullah
AU - Higuchi, Akon
AU - Hanaoka, Kazunori
AU - Nakabayashi, Kazuhiko
AU - Takada, Shuji
AU - Hata, Kenichiro
AU - Toyoda, Masashi
AU - Umezawa, Akihiro
PY - 2016/5/20
Y1 - 2016/5/20
N2 - Disease-specific induced pluripotent stem cells (iPSCs) have been used as a model to analyze pathogenesis of disease. In this study, we generated iPSCs derived from a fibroblastic cell line of xeroderma pigmentosum (XP) group A (XPA-iPSCs), a rare autosomal recessive hereditary disease in which patients develop skin cancer in the areas of skin exposed to sunlight. XPA-iPSCs exhibited hypersensitivity to ultraviolet exposure and accumulation of single-nucleotide substitutions when compared with ataxia telangiectasia-derived iPSCs that were established in a previous study. However, XPA-iPSCs did not show any chromosomal instability in vitro, i.e. intact chromosomes were maintained. The results were mutually compensating for examining two major sources of mutations, nucleotide excision repair deficiency and double-strand break repair deficiency. Like XP patients, XPA-iPSCs accumulated single-nucleotide substitutions that are associated with malignant melanoma, a manifestation of XP. These results indicate that XPA-iPSCs may serve a monitoring tool (analogous to the Ames test but using mammalian cells) to measure single-nucleotide alterations, and may be a good model to clarify pathogenesis of XP. In addition, XPA-iPSCs may allow us to facilitate development of drugs that delay genetic alteration and decrease hypersensitivity to ultraviolet for therapeutic applications.
AB - Disease-specific induced pluripotent stem cells (iPSCs) have been used as a model to analyze pathogenesis of disease. In this study, we generated iPSCs derived from a fibroblastic cell line of xeroderma pigmentosum (XP) group A (XPA-iPSCs), a rare autosomal recessive hereditary disease in which patients develop skin cancer in the areas of skin exposed to sunlight. XPA-iPSCs exhibited hypersensitivity to ultraviolet exposure and accumulation of single-nucleotide substitutions when compared with ataxia telangiectasia-derived iPSCs that were established in a previous study. However, XPA-iPSCs did not show any chromosomal instability in vitro, i.e. intact chromosomes were maintained. The results were mutually compensating for examining two major sources of mutations, nucleotide excision repair deficiency and double-strand break repair deficiency. Like XP patients, XPA-iPSCs accumulated single-nucleotide substitutions that are associated with malignant melanoma, a manifestation of XP. These results indicate that XPA-iPSCs may serve a monitoring tool (analogous to the Ames test but using mammalian cells) to measure single-nucleotide alterations, and may be a good model to clarify pathogenesis of XP. In addition, XPA-iPSCs may allow us to facilitate development of drugs that delay genetic alteration and decrease hypersensitivity to ultraviolet for therapeutic applications.
UR - http://www.scopus.com/inward/record.url?scp=84971013910&partnerID=8YFLogxK
U2 - 10.1038/srep26342
DO - 10.1038/srep26342
M3 - 期刊論文
C2 - 27197874
AN - SCOPUS:84971013910
SN - 2045-2322
VL - 6
JO - Scientific Reports
JF - Scientific Reports
M1 - 26342
ER -